Insiders Lipocine Inc.

Equities

LPCN

US53630X2036

Market Closed - Nasdaq Other stock markets 21:30:00 09/05/2024 BST			5-day change	1st Jan Change
5.24 ^USD	+8.04%		+11.49%	+87.81%

05-09	Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M	MT
05-01	Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lipocine Inc. Announces Senior Leadership Appointments to Advance Its CNS-Focused Pipeline	03/11/22	CI
Lipocine Inc. Announces Board Appointments	11/04/22	CI
Clene Names Morgan Brown as Finance Chief	01/02/22	MT
Lipocine Chief Financial Officer is Retiring	21/01/22	MT
Lipocine Inc. Announces Executive Changes	21/01/22	CI
Lipocine Inc. Announces Resignation of Gregory Bass as Executive Vice President and Chief Commercial Officer, Effective on August 27, 2018	17/08/18	CI
Lipocine Inc. Terminates the Employment of Jyrki Mattila as Executive Vice President and Chief Business Officer	07/07/17	CI
Lipocine Inc. Announces the Promotion of Gregory Bass to Executive Vice President and Chief Commercial Officer	15/02/17	CI
Lipocine Appoints Jyrki Mattila as Executive Vice President and Chief Business Officer	19/05/15	CI
Lipocine Inc. Announces Board Resignations	14/11/14	CI
Lipocine Inc. Announces Changes to the Board of Directors	07/01/14	CI
Lipocine Inc. Appoints Morgan Brown as Executive Vice President and Chief Financial Officer	16/09/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer